COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Phase 1 Study of ATR-002

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04385420
Recruitment Status : Completed
First Posted : May 12, 2020
Last Update Posted : May 13, 2020
SGS Life Sciences, a division of SGS Belgium NV
Information provided by (Responsible Party):
Atriva Therapeutics GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 26, 2019
Actual Study Completion Date : August 26, 2019